Date | Subject |
---|
2022-05-18 03:07:13 | Why Is There a Steady Decrease in Testosterone Levels of Men in the U.S? $CRXT $CRXTW Jatenzo |
2022-05-18 01:19:00 | Clarus Therapeutics Announces Issuance of Patent Covering JATENZO (testosterone undecanoate) $CRXT $CRXTW |
2022-05-17 07:12:59 | NEW PATENT APPROVAL $CRXT $CRXTW |
2022-05-16 07:16:03 | $CRXT $CRXTW-An estimated 20 million men in the United States have hypogonadism, with approximately six million patients diagnosed. Treatments for male hypogonadism may include testosterone replacement therapy. |
2022-05-16 06:20:13 | Clinical experience with testosterone undecanoate capsules (Jatenzo): The first 50 patients $CRXT $CRXTW |